John D Hainsworth Selected Research

John D Hainsworth Research Topics

Disease

77	Neoplasms (Cancer) 01/2022 - 02/2001
31	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 02/2001
21	Carcinoma (Carcinomatosis) 03/2016 - 03/2002
17	Disease Progression 01/2021 - 04/2003
16	Renal Cell Carcinoma (Grawitz Tumor) 10/2021 - 11/2005
16	Neutropenia 08/2015 - 07/2002
14	Diarrhea 11/2015 - 05/2003
13	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 05/2002
11	Fatigue 10/2012 - 01/2004
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2009 - 02/2002
8	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 03/2006
7	Hypertension (High Blood Pressure) 01/2022 - 05/2005
7	Adenocarcinoma 08/2015 - 04/2005
7	Thrombocytopenia (Thrombopenia) 10/2012 - 03/2003
6	Neoplasm Metastasis (Metastasis) 10/2018 - 06/2005
6	Exanthema (Rash) 09/2017 - 12/2007
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2015 - 01/2003
5	Anemia 11/2015 - 01/2010
5	Colorectal Neoplasms (Colorectal Cancer) 06/2012 - 05/2005
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2008 - 01/2003
4	Pathologic Complete Response 04/2020 - 07/2002
4	Stomatitis 03/2016 - 12/2011
4	Infections 03/2016 - 10/2011
4	Lung Neoplasms (Lung Cancer) 03/2016 - 05/2003
4	Esophageal Neoplasms (Esophageal Cancer) 07/2012 - 02/2001
4	Nausea 12/2011 - 11/2005
3	Glioblastoma (Glioblastoma Multiforme) 09/2019 - 08/2010
3	Hemorrhage 01/2018 - 05/2005
3	Triple Negative Breast Neoplasms 08/2017 - 08/2015
3	Melanoma (Melanoma, Malignant) 01/2016 - 09/2010
3	Carcinoid Tumor (Carcinoid) 12/2015 - 12/2011
3	Basal Cell Carcinoma (Rodent Ulcer) 06/2015 - 06/2012
3	Ovarian Neoplasms (Ovarian Cancer) 05/2015 - 09/2006
3	Lymphoma (Lymphomas) 04/2015 - 01/2003
3	Hypersensitivity (Allergy) 10/2012 - 05/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2011 - 07/2002
3	Head and Neck Neoplasms (Head and Neck Cancer) 09/2011 - 07/2002
3	Vomiting 10/2010 - 11/2005
3	Fever (Fevers) 10/2010 - 07/2002
3	Brain Neoplasms (Brain Tumor) 03/2010 - 03/2003

Drug/Important Bio-Agent (IBA)

39	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 03/2002
31	Paclitaxel (Taxol)FDA LinkGeneric 08/2017 - 02/2001
30	Bevacizumab (Avastin)FDA Link 09/2019 - 05/2005
22	Gemcitabine FDA Link 10/2016 - 02/2001
20	Docetaxel (Taxotere)FDA Link 01/2019 - 02/2001
16	Rituximab (Mabthera)FDA Link 08/2015 - 02/2002
14	Everolimus FDA Link 10/2021 - 05/2010
14	taxaneIBA 04/2020 - 01/2002
12	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 11/2005
11	Pharmaceutical PreparationsIBA 12/2011 - 02/2002
10	Sunitinib (Sutent)FDA Link 10/2021 - 05/2010
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 06/2003
10	Sorafenib (BAY 43-9006)FDA Link 11/2017 - 01/2010
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 05/2005
9	ErbB Receptors (EGF Receptor)IBA 10/2018 - 11/2005
9	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 01/2002
9	Irinotecan (Camptosar)FDA LinkGeneric 08/2012 - 05/2003
8	Trastuzumab (Herceptin)FDA Link 01/2018 - 10/2008
8	Prednisone (Sone)FDA LinkGeneric 01/2017 - 06/2003
8	Etoposide (VP 16)FDA LinkGeneric 01/2010 - 05/2002
7	Hormones (Hormone)IBA 01/2020 - 11/2003
7	Pemetrexed (MTA)FDA Link 12/2019 - 06/2010
7	Fluorouracil (Carac)FDA LinkGeneric 07/2012 - 01/2002
6	AnthracyclinesIBA 04/2020 - 08/2006
6	Vinorelbine (Navelbine)FDA LinkGeneric 08/2009 - 02/2001
5	PlatinumIBA 01/2018 - 05/2002
5	ixabepilone (BMS 247550)FDA Link 08/2017 - 10/2012
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2011 - 07/2008
5	Topotecan (Hycamtin)FDA LinkGeneric 05/2011 - 05/2002
5	Gefitinib (Iressa)FDA Link 01/2010 - 05/2003
4	Taxoids (Taxanes)IBA 01/2019 - 08/2006
4	HhAntag691IBA 01/2018 - 06/2012
4	Vincristine (Oncovin)FDA LinkGeneric 08/2015 - 06/2003
4	Capecitabine (Xeloda)FDA Link 05/2010 - 07/2008
4	Monoclonal AntibodiesIBA 09/2005 - 01/2003
3	AndrogensIBA 01/2022 - 05/2011
3	pegfilgrastim (Neulasta)FDA Link 01/2018 - 06/2008
3	Epidermal Growth Factor (EGF)IBA 01/2018 - 05/2010
3	pazopanib FDA Link 01/2018 - 09/2013
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2016 - 08/2010
3	Octreotide (Sandostatin)FDA LinkGeneric 12/2015 - 12/2011
3	Abiraterone AcetateIBA 10/2015 - 05/2011
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2013 - 09/2008
3	Cytotoxins (Cytolysins)IBA 10/2012 - 08/2006
3	Temozolomide (Temodar)FDA LinkGeneric 04/2012 - 05/2003
3	Angiogenesis InhibitorsIBA 08/2011 - 01/2010
3	vinflunineIBA 11/2010 - 03/2010
3	Epirubicin (Ellence)FDA LinkGeneric 10/2010 - 08/2006
3	Imatinib Mesylate (Gleevec)FDA Link 11/2009 - 09/2007
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 09/2012

Therapy/Procedure

57	Therapeutics 10/2021 - 02/2002
42	Drug Therapy (Chemotherapy) 01/2018 - 02/2001
12	Radiotherapy 01/2016 - 02/2001
11	Neoadjuvant Therapy 04/2020 - 06/2008
10	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 03/2002
6	Castration 01/2017 - 03/2010
5	Combined Modality Therapy 04/2012 - 07/2002
3	Aftercare (After-Treatment) 01/2017 - 05/2010
3	Induction Chemotherapy 09/2011 - 02/2001